Feds, States Won't Join Allergan Glaucoma Drug FCA Suit
The federal government and dozens of states declined to join a whistleblower lawsuit accusing Allergan Inc. of concealing the health risks of its glaucoma medicine and subsequently collecting reimbursements from public...To view the full article, register now.
Already a subscriber? Click here to view full article